Navigation Links
CEL-SCI Corporation Releases Letter to Shareholders
Date:10/5/2009

VIENNA, Va., Oct. 5 /PRNewswire-FirstCall/ -- The following letter is being released by CEL-SCI Corporation (NYSE AMEX: CVM) to its shareholders:

Dear Fellow Shareholders:

After FDA had communicated several weeks ago that we could proceed with our initial clinical trial with our proposed H1N1 treatment for hospitalized H1N1 patients, we have received many questions with regards to H1N1. With this in mind, we have asked one of our outside collaborators, Ken S. Rosenthal, Ph.D., Professor, Microbiology, Immunology and Biochemistry, Northeastern Ohio Universities Colleges of Medicine and Pharmacology, to help explain in layman's terms the course of the H1N1 disease and why it can be so dangerous. Dr. Rosenthal also has provided an explanation of how CEL-SCI's investigational H1N1 treatment may help in very sick hospitalized patients. Dr. Rosenthal explains:

Background information on influenza and H1N1 influenza:

Influenza infection could have very mild consequences or cause very severe disease. At the least, it may seem like a severe cold and at the worst, it can be life-threatening. Influenza is a respiratory virus spread in the tiny water droplets that we release every time we exhale and then are inhaled by another person. These droplets enter the mouth and nose and travel down the throat and into the lungs. When influenza infects a person's lungs, there are three destructive components working together to cause disease: the virus's ability to kill the lung cells; the immune system's inflammatory reactions that kill influenza infected cells; and bacterial infections that establish themselves in the diseased environment.

Influenza virus infects the ciliated epithelial cells of the respiratory tract that help keep foreign material out of the lungs. The virus attaches to these cells through specific sugar molecules, called sialic acids, on the proteins and lipids on t
'/>"/>

SOURCE CEL-SCI Corporation
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. CEL-SCI Hires Clinical Research Organization for Clinical Study With Hospitalized H1N1-Infected Patients
2. CEL-SCI Expands H1N1 Flu Virus Work
3. CEL-SCI to Present Data from Multikine Clinical Trials at National Institutes of Health (NIH), National Cancer Institute (NCI) Seminar Series
4. CEL-SCI Posts New Corporate Presentation to Website
5. CEL-SCI Corporation Releases Letter to Shareholders
6. CEL-SCI Corporation Releases Letter to Shareholders
7. CEL-SCI Announces Expansion of Exclusive Licensing Agreement for Cancer Drug Multikine
8. CEL-SCI Enters Agreement With National Institutes of Health Clinical Center To Determine the Molecular Basis of Multikine Anti-Tumor Effect
9. CEL-SCI Expects to Take Delivery of New Manufacturing Facility on October 8, 2008
10. Data Suggest CEL-SCIs CEL-2000 Vaccine Prevents or Retards Permanent Damage of Rheumatoid Arthritis
11. CEL-SCI Corporation Reports First Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... Therapeutics, Inc. (Nasdaq: OREX ) today announced that ... Healthcare Conference in New York . The ... 11 a.m. Eastern Time. To listen to the live webcast ... Relations section of the Company,s Web site at www.orexigen.com ... the event. About Orexigen® Therapeutics Orexigen Therapeutics, ...
(Date:5/17/2013)... and CAMBRIDGE, Mass., May 17, 2013   ... a purchaser of Aveo Pharmaceutical, Inc. (NASDAQGS: AVEO) securities ... for the District of Massachusetts . ... officers violated the Securities Exchange Act of 1934 (the ... 2013 (the "Class Period"). (Logo: http://photos.prnewswire.com/prnh/20130103/MM36754LOGO ...
(Date:5/17/2013)... 17, 2013  Sony Biotechnology Inc. ("Sony") today announced ... (SP6800).  Sony will be exhibiting and taking orders for ... at the San Diego Convention ... from May 20 - 22.  The ... commercial audio-visual technologies into new and novel functionalities for ...
Breaking Medicine Technology:Aveo Pharmaceuticals, Inc. Sued by Investor 2Aveo Pharmaceuticals, Inc. Sued by Investor 3Sony Biotechnology Inc.'s New Technology for Science Provides Researchers Results in Color 2
... , , , Letters ... , DES PLAINES, Ill., Sept. 10 The American Brain Tumor ... and creative research ideas for solving the challenges of brain tumor diagnosis and ... scientific breakthroughs over the past decade resulting in better treatments and longer lives ...
... EMERYVILLE, Calif., Sept. 10 NovaBay(R) Pharmaceuticals, Inc. (NYSE-Amex: ... clinical stage company developing novel anti-infective compounds for the treatment ... fungal infections, announced today the start of a Phase 2a ... , , NovaBay,s partner in ...
Cached Medicine Technology:American Brain Tumor Association Calls for Discovery Research 2NovaBay Launches Clinical Study for Non-Antibiotic Treatment of Impetigo, One of the Most Common Skin Infections 2NovaBay Launches Clinical Study for Non-Antibiotic Treatment of Impetigo, One of the Most Common Skin Infections 3NovaBay Launches Clinical Study for Non-Antibiotic Treatment of Impetigo, One of the Most Common Skin Infections 4
(Date:5/19/2013)... Daily Gossip reporters have subjected Joel Marion and Brett ... Fat to a close analysis with the intention to ... is a detailed explanation of the diet suggested by ... two nutritionists have discovered during their research that there is ... and expenditure of our body, that is, the leptin hormone. ...
(Date:5/19/2013)... Reporter , , SATURDAY, May 18 (HealthDay News) -- ... disease overcome the fatigue and decreased muscle strength ... new research. Extra vitamin D "was associated ... greater quality of life and the ability to ... a research dietitian and doctoral candidate at Trinity ...
(Date:5/19/2013)... May 19, 2013 People in Minnesota have ... Altman Fitness is offering its 28 Day Fat Loss Formula. ... from the comfort of their own home. The product sells ... More information can be accessed here: http://altmanfitness.com/28-day-fat-loss-formula/ , ... leave their houses now, but after using the 28 Day ...
(Date:5/19/2013)... Los Angeles, California (PRWEB) May 19, 2013 ... more damage than just losing sleep, or annoying your ... 9, 2013 report by CNY Central (“Snoring and Teeth ... a certain type of teeth grinding can be hard ... around 12 million Americans, and one of its symptoms ...
(Date:5/19/2013)... Fat Burning Furnace developed by Rob Poulos ... with fat burning diet plans, training workouts, ... Furnace package, people will receive the Fat Burning Furnace ... The Fat Burning Furnace manual includes fat loss knowledge, ... mass. In addition, this book covers step-by-step instructions, techniques ...
Breaking Medicine News(10 mins):Health News:The "17 Cheat Foods That Burn Fat" Review and Diet Plan Secrets Revealed by Daily Gossip 2Health News:Extra Vitamin D May Ease Crohn's Symptoms, Study Finds 2Health News:Extra Vitamin D May Ease Crohn's Symptoms, Study Finds 3Health News:Dr. Kanani, Woodland Hills Dentist: Dangers of Tooth Damage and Obstructive Sleep Disorder 2Health News:Dr. Kanani, Woodland Hills Dentist: Dangers of Tooth Damage and Obstructive Sleep Disorder 3Health News:Fat Burning Diet | How “Fat Burning Furnace” Helps People Lose Their Weight Naturally And Fast – V-kool 2
... HealthDay Reporter , MONDAY, Feb. 28 (HealthDay News) -- Instructions ... sometimes taking an average of seven pills a day, may ... many patients don,t realize that they can take several medications ... easy to grasp are sorely needed, the researchers added. ...
... the failure of enzymes to break down specific kinds of ... severe physical and neurological problems and sometimes early death. ... of the Journal of Biological Chemistry , researchers at ... by Jeffrey D. Esko, PhD, professor in the Department of ...
... Researchers at the Cummings School of Veterinary Medicine have received ... Syndrome (HUS), a potentially fatal outcome of E. coli ... children. HUS is caused by the forms of ... for about 100,000 annual cases of illness in the United ...
... WASHINGTON, February 28, 2011) Results from a study ... American Society of Hematology reveal a close relationship between ... arteries carrying blood from the heart to the lungsand ... (known as myeloid abnormalities). The study, which was ...
... , MONDAY, Feb. 28 (HealthDay News) -- A ... of depression are less likely than other heart attack patients ... analyzed data on 6,874 heart attack patients admitted to 96 ... March 2005. Of these patients, 680 had a history of ...
... Kansas State University chemistry professor has been selected as ... promising young scholar, particularly in the research areas of ... professor of chemistry, has received the two-year $50,000 award, ... early-career scientists and scholars as a way to recognize ...
Cached Medicine News:Health News:Confusion Over Drug Dosing Common for Seniors 2Health News:Confusion Over Drug Dosing Common for Seniors 3Health News:New marker found for Sanfilippo disease 2Health News:Tufts receives patent for antibody treatment against hemolytic uremic syndrome 2Health News:Study finds close linkage between a rare, deadly lung condition and blood cell abnormalities 2Health News:Heart Patients With Depression Often Find ER Delays 2Health News:K-State chemist's work brings more national recognition as promising early-career scientist 2
... The OSOM Ultra Strep A Test is ... Technology (DLT)**. DLT uses antibody labeled color ... the test device. DLT allows greater sensitivity ... sacrificing specificity. In the test procedure, a ...
... The female Fertell test is an easy ... that measures ovarian reserve by means of determining ... an in-stream urine sample. The test is performed ... 3 of the menstrual cycle) and is similar ...
... The Cholestech GDX System delivers an unmatched ... the ideal solution for assessing and monitoring a ... product demo, click here ., ,The CLIA-waived ... delivers A1C results in less than 5 minutes. ...
... using patented, innovative technology, measures a complete ... only 5 minutes from a simple fingerstick. ... get immediate liver function results. The scope ... only advantage to healthcare providers. The physician, ...
Medicine Products: